Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double‐blind, randomized, controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8249|78|2|248-257

ISSN： 0364-5134

Source： ANNALS OF NEUROLOGY, Vol.78, Iss.2, 2015-08, pp. : 248-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 329-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transdermal rotigotine in early stage Parkinson's disease: A randomized, double‐blind, placebo‐controlled trial

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1447-1450

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1407-1415

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 1351-5101, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite